Stephen Barker
Stock Analyst at Jefferies
(3.65)
# 2,032
Out of 4,339 analysts
101
Total ratings
45.3%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Stephen Barker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 7733 Olympus Corporation | Upgraded: Buy | $1,700 → $2,300 | $1,773.00 | +29.72% | 4 | May 18, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Maintained: Hold | $9,100 → $8,500 | $7,680.00 | +10.68% | 7 | May 12, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | $4,600 → $3,100 | $2,692.00 | +15.16% | 13 | May 6, 2026 | |
| TYO: 8086 Nipro Corporation | Maintained: Hold | $1,500 | $1,721.00 | -12.84% | 1 | Apr 30, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | $12,500 | $11,520.00 | +8.51% | 10 | Apr 26, 2026 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Hold | $4,600 → $5,000 | $4,005.00 | +24.84% | 8 | Apr 14, 2026 | |
| TYO: 7747 Asahi Intecc Co., Ltd. | Reiterated: Buy | $4,200 | $3,627.00 | +15.80% | 7 | Apr 12, 2026 | |
| TYO: 2160 GNI Group Ltd. | Maintained: Buy | $3,600 → $3,800 | $2,706.00 | +40.43% | 3 | Apr 3, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Buy | $1,500 → $2,800 | $2,220.00 | +26.13% | 7 | Mar 24, 2026 | |
| TYO: 6869 Sysmex Corporation | Maintained: Hold | $3,300 → $1,500 | $1,345.50 | +11.48% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2,100 → $2,700 | $1,576.00 | +71.32% | 9 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2,500 → $3,000 | $2,402.00 | +24.90% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1,900 → $1,700 | $1,944.50 | -12.57% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7,400 → $2,500 | $3,010.00 | n/a | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3,400 → $4,100 | $4,180.00 | n/a | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2,300 → $1,800 | $2,404.50 | n/a | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $560 → $660 | $483.00 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $320 | $316.00 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3,350 → $3,500 | $2,329.00 | n/a | 4 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4,800 → $5,000 | $5,051.00 | n/a | 4 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2,700 | $1,169.00 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3,600 | $4,005.00 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $579.60 | n/a | 1 | Feb 1, 2019 |
Olympus Corporation
May 18, 2026
Upgraded: Buy
Price Target: $1,700 → $2,300
Current: $1,773.00
Upside: +29.72%
Chugai Pharmaceutical Co., Ltd.
May 12, 2026
Maintained: Hold
Price Target: $9,100 → $8,500
Current: $7,680.00
Upside: +10.68%
Daiichi Sankyo Company, Limited
May 6, 2026
Reiterated: Buy
Price Target: $4,600 → $3,100
Current: $2,692.00
Upside: +15.16%
Nipro Corporation
Apr 30, 2026
Maintained: Hold
Price Target: $1,500
Current: $1,721.00
Upside: -12.84%
Otsuka Holdings Co., Ltd.
Apr 26, 2026
Reiterated: Buy
Price Target: $12,500
Current: $11,520.00
Upside: +8.51%
Eisai Co., Ltd.
Apr 14, 2026
Maintained: Hold
Price Target: $4,600 → $5,000
Current: $4,005.00
Upside: +24.84%
Asahi Intecc Co., Ltd.
Apr 12, 2026
Reiterated: Buy
Price Target: $4,200
Current: $3,627.00
Upside: +15.80%
GNI Group Ltd.
Apr 3, 2026
Maintained: Buy
Price Target: $3,600 → $3,800
Current: $2,706.00
Upside: +40.43%
Astellas Pharma Inc.
Mar 24, 2026
Maintained: Buy
Price Target: $1,500 → $2,800
Current: $2,220.00
Upside: +26.13%
Sysmex Corporation
Mar 16, 2026
Maintained: Hold
Price Target: $3,300 → $1,500
Current: $1,345.50
Upside: +11.48%
Dec 15, 2025
Maintained: Buy
Price Target: $2,100 → $2,700
Current: $1,576.00
Upside: +71.32%
Sep 10, 2025
Maintained: Buy
Price Target: $2,500 → $3,000
Current: $2,402.00
Upside: +24.90%
Aug 8, 2025
Downgraded: Hold
Price Target: $1,900 → $1,700
Current: $1,944.50
Upside: -12.57%
Oct 25, 2024
Maintained: Hold
Price Target: $7,400 → $2,500
Current: $3,010.00
Upside: n/a
Oct 21, 2024
Maintained: Hold
Price Target: $3,400 → $4,100
Current: $4,180.00
Upside: n/a
Sep 23, 2024
Maintained: Hold
Price Target: $2,300 → $1,800
Current: $2,404.50
Upside: n/a
Sep 11, 2024
Maintained: Hold
Price Target: $560 → $660
Current: $483.00
Upside: n/a
Sep 9, 2024
Upgraded: Buy
Price Target: $320
Current: $316.00
Upside: n/a
Sep 2, 2024
Maintained: Buy
Price Target: $3,350 → $3,500
Current: $2,329.00
Upside: n/a
Aug 13, 2024
Maintained: Buy
Price Target: $4,800 → $5,000
Current: $5,051.00
Upside: n/a
Aug 1, 2024
Maintained: Hold
Price Target: $2,700
Current: $1,169.00
Upside: n/a
Jul 30, 2024
Maintained: Hold
Price Target: $3,600
Current: $4,005.00
Upside: n/a
Feb 1, 2019
Upgraded: Buy
Price Target: n/a
Current: $579.60
Upside: n/a